Review : Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal Liver Lesions
분야
의약학 > 내과학
저자
( Jae Young Jang ) , ( Moon Young Kim ) , ( Soung Won Jeong ) , ( Tae Yeob Kim ) , ( Seung Up Kim ) , ( Sae Hwan Lee ) , ( Ki Tae Suk ) , ( Soo Young Park ) , ( Hyun Young Woo ) , ( Sang Gyune Kim ) , ( Jeong Heo ) , ( Soon Koo Baik ) , ( Hong Soo Kim ) ,
발행기관
대한간학회
간행물정보
Clinical and Molecular Hepatology(대한간학회지) 2013년, 제19권 제1호, 1~16페이지(총16페이지)
파일형식
27405552.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    5,600원
    적립금
    168원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    The application of ultrasound contrast agents (UCAs) is considered essential when evaluating focal liver lesions (FLLs) using ultrasonography (US). Microbubble UCAs are easy to use and robust; their use poses no risk of nephrotoxicity and requires no ionizing radiation. The unique features of contrast enhanced US (CEUS) are not only noninvasiveness but also real-time assessing of liver perfusion throughout the vascular phases. The later feature has led to dramatic improvement in the diagnostic accuracy of US for detection and characterization of FLLs as well as the guidance to therapeutic procedures and evaluation of response to treatment. This article describes the current consensus and guidelines for the use of UCAs for the FLLs that are commonly encountered in US. After a brief description of the bases of different CEUS techniques, contrast-enhancement patterns of different types of benign and malignant FLLs and other clinical applications are described and discussed on the basis of our experience and the literature data. (Clin Mol Hepatol 2013;19:1-16)
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.